Loading
Latest filing published 12 Jun 2026 for 아이엠바이오로직스.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 하경식 in 아이엠바이오로직스, where the filings describe the role as chief executive. We count 3 filings; the first trade dates from 20 March 2026 and the latest from 12 June 2026.
Market trades split into 2 purchases and 1 sale. The totals do not cover 3 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 12 June 2026 came the latest disclosure, an open-market sale in 아이엠바이오로직스. The last purchase on record was published on 30 March 2026, which is 209 days ago. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.